Literature DB >> 19888532

Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram.

Kellie R Machlus1, Emily A Colby, Jogin R Wu, Gary G Koch, Nigel S Key, Alisa S Wolberg.   

Abstract

Elevated procoagulant levels have been correlated with increased thrombin generation in vitro and with increased venous thromboembolism (VTE) risk in epidemiological studies. Thrombin generation tests are increasingly being employed as a high throughput method to provide a global measure of procoagulant activity in plasma samples. The objective of this study was to distinguish the effects of assay conditions [tissue factor (TF), thrombomodulin, platelets/lipids] and factor levels on thrombin generation parameters, and determine the conditions and parameters with the highest sensitivity and specificity for detecting elevated factor levels. Thrombin generation was measured using calibrated automated thrombography (CAT) in corn trypsin inhibitor (CTI)-treated platelet-free plasma (PFP) and platelet-rich plasma (PRP). Statistical analysis was performed using logarithms of observed values with analysis of variance that accounted for experiment and treatment. The relative sensitivity of lag time (LT), time to peak (TTP), peak height and endogenous thrombin potential (ETP) to elevated factors XI, IX, VIII, X, and prothrombin was as follows: PFP initiated with 1 pM TF > PFP initiated with 5 pM TF > PRP initiated with 1 pM TF. For all conditions, inclusion of thrombomodulin prolonged the LT and decreased the peak and ETP; however, addition of thrombomodulin did not increase the ability of CAT to detect elevated levels of individual procoagulant factors. In conclusion, CAT conditions differentially affected the sensitivity of thrombin generation to elevated factor levels. Monitoring the peak height and/or ETP following initiation of clotting in PFP with 1 pM TF was most likely to detect hypercoagulability due to increased procoagulant factor levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888532      PMCID: PMC2904819          DOI: 10.1160/TH09-03-0180

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  38 in total

1.  Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin.

Authors:  D D Monković; P B Tracy
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

2.  Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes.

Authors:  D L Sauls; A E Banini; L C Boyd; M Hoffman
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

3.  Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor.

Authors:  Y Dargaud; R Luddington; T P Baglin
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  The role of factor XI in thrombin generation induced by low concentrations of tissue factor.

Authors:  I M Keularts; A Zivelin; U Seligsohn; H C Hemker; S Béguin
Journal:  Thromb Haemost       Date:  2001-06       Impact factor: 5.249

5.  More on: high thrombin generation and the risk of recurrent venous thromboembolism.

Authors:  A Tripodi; C Legnani; G Palareti; V Chantarangkul; P M Mannucci
Journal:  J Thromb Haemost       Date:  2009-03-06       Impact factor: 5.824

6.  High levels of factor IX increase the risk of venous thrombosis.

Authors:  A van Hylckama Vlieg; I K van der Linden; R M Bertina; F R Rosendaal
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

7.  Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.

Authors:  A van Hylckama Vlieg; S C Christiansen; R Luddington; S C Cannegieter; F R Rosendaal; T P Baglin
Journal:  Br J Haematol       Date:  2007-09       Impact factor: 6.998

8.  Calibrated automated thrombin generation in frozen-thawed platelet-rich plasma to detect hypercoagulability.

Authors:  Véronique Regnault; Suzette Béguin; Thomas Lecompte
Journal:  Pathophysiol Haemost Thromb       Date:  2003

9.  Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics.

Authors:  K Vanschoonbeek; M A H Feijge; R J W Van Kampen; H Kenis; H C Hemker; P L A Giesen; J W M Heemskerk
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

10.  High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.

Authors:  M Besser; C Baglin; R Luddington; A van Hylckama Vlieg; T Baglin
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

View more
  31 in total

1.  Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis.

Authors:  Robert A Campbell; Adriana Vieira-de-Abreu; Jesse W Rowley; Zechariah G Franks; Bhanu Kanth Manne; Matthew T Rondina; Larry W Kraiss; Jennifer J Majersik; Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

2.  A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy.

Authors:  C R Krebs; Ling Li; Alisa S Wolberg; Amy L Oldenburg
Journal:  Rev Sci Instrum       Date:  2015-07       Impact factor: 1.523

3.  Air pollution upregulates endothelial cell procoagulant activity via ultrafine particle-induced oxidant signaling and tissue factor expression.

Authors:  S J Snow; W Cheng; A S Wolberg; M S Carraway
Journal:  Toxicol Sci       Date:  2014-04-20       Impact factor: 4.849

4.  Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.

Authors:  Laura D Gray; Michael A Hussey; Brittany M Larson; Kellie R Machlus; Robert A Campbell; Gary Koch; Mirella Ezban; Ulla Hedner; Alisa S Wolberg
Journal:  Thromb Res       Date:  2011-05-10       Impact factor: 3.944

Review 5.  New findings on venous thrombogenesis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Hamostaseologie       Date:  2016-11-23       Impact factor: 1.778

6.  Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.

Authors:  Jessica C Cardenas; A Phillip Owens; Janakiraman Krishnamurthy; Norman E Sharpless; Herbert C Whinna; Frank C Church
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-13       Impact factor: 8.311

Review 7.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

Review 8.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

9.  Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography.

Authors:  Marina Marchetti; Erika Diani; Hugo ten Cate; Anna Falanga
Journal:  Haematologica       Date:  2012-03-14       Impact factor: 9.941

10.  Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.

Authors:  M Zucker; U Seligsohn; O Salomon; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.